نتائج البحث - "Begic, D"

1

Academic Journal

Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.

المساهمون: Université de Lille, Inserm, CHU Lille, Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286, CRLCC Eugène Marquis CRLCC, Hôpital de la Croix-Rousse CHU - HCL, CHU Pitié-Salpêtrière AP-HP, Hôpital Saint Eloi CHRU Montpellier

Relation: Lancet Oncol; http://hdl.handle.net/20.500.12210/100999

الاتاحة: https://hdl.handle.net/20.500.12210/100999

View record in BASE

2

Academic Journal

1011P The experience associated with caregiving for patients with intermediate stage hepatocellular carcinoma (HCC) receiving transcatheter arterial chemoembolisation (TACE) treatment

المؤلفون: Edeline, J., Bailey, T., Thompson, G., Wisniewski, T., Taylor-Stokes, G., Begic, D., Bennai, Y.

المصدر: Annals of Oncology ; volume 31, page S700-S701 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1016/j.annonc.2020.08.1127
https://api.elsevier.com/content/article/PII:S0923753420411238?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753420411238?httpAccept=text/plain

View record in BASE

3

Academic Journal

CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)

المؤلفون: Yau, T., Park, J.W., Finn, R.S., Cheng, A.-L., Mathurin, P., Edeline, J., Kudo, M., Han, K.-H., Harding, J.J., Merle, P., Rosmorduc, O., Wyrwicz, L., Schott, E., Choo, S.P., Kelley, R.K., Begic, D., Chen, G., Neely, J., Anderson, J., Sangro, B.

المصدر: Annals of Oncology ; volume 30, page v874-v875 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdz394.029
https://api.elsevier.com/content/article/PII:S0923753419603893?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419603893?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/30/Supplement_5/mdz394.029/30082410/mdz394.029.pdf

View record in BASE

4

Academic Journal

PCN510 HEALTHCARE RESOURCE UTILISATION (HCRU) ASSOCIATED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLISATION (TACE) TREATMENT IN INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA (HCC) PATIENTS IN EUROPE

المؤلفون: Bailey, T., Thompson, G., Taylor-Stokes, G., Ghale, A., Begic, D., Bennai, Y., Wisniewski, T.

المصدر: Value in Health ; volume 22, page S537 ; ISSN 1098-3015

الاتاحة: http://dx.doi.org/10.1016/j.jval.2019.09.702
https://api.elsevier.com/content/article/PII:S1098301519330803?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1098301519330803?httpAccept=text/plain

View record in BASE

5

Academic Journal

Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial

مصطلحات موضوعية: Materias Investigacion::Ciencias de la Salud, Nivolumab, Sorafenib, Hepatocellular carcinoma

وصف الملف: application/pdf

Relation: https://hdl.handle.net/10171/68732

الاتاحة: https://hdl.handle.net/10171/68732

View record in BASE

6

Academic Journal

Abstract No. 117 A phase 3, double-blind, randomized study of nivolumab and Ipilimumab), nivolumab monotherapy, or placebo plus transarterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma

المؤلفون: Sangro, B., Harding, J., Johnson, M., Palmer, D., Edeline, J., Abou-Alfa, G., Cheng, A., Decaens, T., El-Khoueiry, A., Finn, R., Galle, P., Park, J., Yau, T., Begic, D., Shen, Y., Neely, J., Sama, A., Kudo, M.

المصدر: Journal of Vascular and Interventional Radiology ; volume 32, issue 5, page S52-S53 ; ISSN 1051-0443

الاتاحة: http://dx.doi.org/10.1016/j.jvir.2021.03.123
https://api.elsevier.com/content/article/PII:S105104432100508X?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S105104432100508X?httpAccept=text/plain

View record in BASE

7

Academic Journal

Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype

المؤلفون: Begic, D., von Eiff, C., Tsuji, B. T.

المصدر: Journal of Antimicrobial Chemotherapy ; volume 63, issue 5, page 977-981 ; ISSN 0305-7453 1460-2091

الاتاحة: https://doi.org/10.1093/jac/dkp069
http://academic.oup.com/jac/article-pdf/63/5/977/2113705/dkp069.pdf

View record in BASE

8

Academic Journal

Qualitative electroencephalogram (qEEG) in combat veterans with post-traumatic stress disorder (PTSD) / Qualitative electroencephalogram (qEEG) in combat veterans with post-traumatic stress disorder (PTSD)

المؤلفون: Kokic-Begic, N, Begic, D

المصدر: Nordic Journal of Psychiatry. 57(5):351

View record in SveMed+

9

Academic Journal

Quetiapine – adjunctive treatment of major depressive disorder with anxiety symptoms

المؤلفون: Bise, S., Sulejmanpašić, G., Begic, D., Ahmic, M.

المصدر: European Neuropsychopharmacology ; volume 27, page S851-S852 ; ISSN 0924-977X

الاتاحة: http://dx.doi.org/10.1016/s0924-977x(17)31530-4
https://api.elsevier.com/content/article/PII:S0924977X17315304?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0924977X17315304?httpAccept=text/plain

View record in BASE

10

Academic Journal

Antidepressants Augmented with Aripiprazole in the Treatment of Major Depressive Disorder

المؤلفون: Bise, S., Sulejmanpasic, G., Begic, D., Ahmic, M.

المصدر: European Psychiatry ; volume 41, issue S1, page S141-S141 ; ISSN 0924-9338 1778-3585

الاتاحة: http://dx.doi.org/10.1016/j.eurpsy.2017.01.1977
https://api.elsevier.com/content/article/PII:S0924933817319922?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0924933817319922?httpAccept=text/plain
https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0924933800197482

View record in BASE

11

Conference

Efficacy and safety of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in Chinese patients (Pts) with metastatic adenocarcinoma of the pancreas (MPC): A phase II study

المؤلفون: Yu, X., Shen, L., Hao, J., Wang, L., Pan, H., Han, G., Xu, J., Zhang, Y., Yang, S., Ying, J., Li, M., Begic, D., Lu, B., Xu, R.

المساهمون: Fudan Univ, Shanghai Canc Ctr, Dept Pancreat & Hepatobiliary Surg, Shanghai 200433, Peoples R China., Peking Univ, Canc Hosp, Beijing Canc Hosp, Oncol, Beijing 100871, Peoples R China., Tianjin Med Univ Canc Inst & Hosp, Oncol, Tianjin, Peoples R China., 1st Shanghai Peoples Hosp, Oncol, Shanghai, Peoples R China., Zhejiang Univ, Sir Run Run Shaw Hosp, Oncol, Hangzhou 310003, Zhejiang, Peoples R China., 4th Mil Med Univ, Xijing Hosp, Oncol, Xian, Peoples R China., 307th Hosp PLA AMMS China, Oncol, Beijing, Peoples R China., 1st Hosp Harbin Inst Hematol, Oncol, Harbin, Peoples R China., Henan Prov Anticanc Hosp, Oncol, Zhengzhou, Peoples R China., Zhejiang Canc Hosp, Oncol, Hangzhou, Zhejiang, Peoples R China., Celgene, Biostat, Summit, NJ USA., Celgene, CR&D, Summit, NJ USA., Sun Yat Sen Univ, Affiliated Hosp 1, Oncol, Guangzhou 510275, Guangdong, Peoples R China.

المصدر: SCI

Relation: ANNALS OF ONCOLOGY.2015,26,66-67.; 1535031; http://hdl.handle.net/20.500.11897/460245; WOS:000367158700223

الاتاحة: https://hdl.handle.net/20.500.11897/460245

View record in BASE

Full Text Finder